Behavioral Activation + Cognitive Processing Therapy for PTSD and Comorbid MDD
1 other identifier
interventional
100
1 country
1
Brief Summary
This study is a randomized controlled trial comparing an integrated treatment, Behavioral Activation + Cognitive Processing Therapy (BA + CPT), to CPT alone among active-duty service members with posttraumatic stress disorder (PTSD) and comorbid major depressive disorder (MDD). Participants will complete assessor-administered and self-report measures at pre- and post-treatment assessments, as well as a 3-month follow-up. Additionally, participants will complete self-report measures of PTSD and MDD symptoms at each therapy session.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 20, 2015
CompletedFirst Submitted
Initial submission to the registry
August 2, 2016
CompletedFirst Posted
Study publicly available on registry
August 22, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 18, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 18, 2022
CompletedNovember 15, 2024
November 1, 2024
6.4 years
August 2, 2016
November 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Montgomery-Asberg Depression Rating Scale (MADRS)
Assessor-administered measure of depression symptoms
Prior to beginning treatment through three months following treatment completion (approximately 10 months)
Secondary Outcomes (2)
Clinician-Administered PTSD Scale for the DSM-5 (CAPS-5)
Prior to beginning treatment through three months following treatment completion (approximately 10 months)
Patient Health Questionnaire (PHQ-9)
Prior to beginning treatment through three months following treatment completion (approximately 10 months)
Study Arms (2)
Behavioral Activation + CPT
EXPERIMENTALBehavioral Activation, an evidence-based treatment for depression, is combined with Cognitive Processing Therapy (CPT), an evidence-based treatment for PTSD, to address symptoms of PTSD and comorbid MDD.
Cognitive Processing Therapy
ACTIVE COMPARATORCPT is an evidence-based treatment for PTSD that has also been shown to reduce depression symptoms.
Interventions
Cognitive processing therapy
Eligibility Criteria
You may qualify if:
- Active-duty service member seeking mental health treatment at Naval Medical Center San Diego (NMCSD), branch clinics, or Naval Hospital Camp Pendleton (NHCP)
- Meet current diagnostic criteria for PTSD based on the DSM-5 as a consequence of any index traumatic event (e.g., combat, military sexual trauma, child abuse, accidents, etc.)
- Meet current diagnostic criteria for MDD based on DSM-5 criteria.
You may not qualify if:
- Unmanaged psychosis or manic episode in the past year
- Substance use disorder warranting primary substance use treatment or detoxification
- Participation in concurrent psychotherapies directly targeting PTSD
- Participation in concurrent psychotherapies directly targeting depression
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Naval Medical Center San Diego
San Diego, California, 92134, United States
Related Publications (5)
Walter KH, Glassman LH, Michael Hunt W, Otis NP, Thomsen CJ. Evaluation of an integrated treatment for active duty service members with comorbid posttraumatic stress disorder and major depressive disorder: Study protocol for a randomized controlled trial. Contemp Clin Trials. 2018 Jan;64:152-160. doi: 10.1016/j.cct.2017.10.010. Epub 2017 Nov 7.
PMID: 29107036BACKGROUNDWalter KH, Hunt WM, Otis NP, Kline AC, Miggantz EL, Thomsen CJ, Glassman LH. Comparison of behavioral activation-enhanced cognitive processing therapy and cognitive processing therapy among U.S. service members: A randomized clinical trial. Psychiatry Res. 2023 Aug;326:115330. doi: 10.1016/j.psychres.2023.115330. Epub 2023 Jul 4.
PMID: 37418778RESULTKline AC, Otis NP, Norman SB, Hunt WM, Walter KH. Dropout in a clinical trial for comorbid PTSD and MDD among US service members: Are pretreatment characteristics predictive? Psychother Res. 2025 Apr;35(4):614-626. doi: 10.1080/10503307.2024.2325519. Epub 2024 Mar 18.
PMID: 38497740RESULTGlassman LH, Otis NP, Kline AC, Hunt WM, Walter KH. Sex differences in treatment outcomes among U.S. service members with comorbid PTSD and MDD. BMC Psychol. 2026 Jan 31. doi: 10.1186/s40359-025-03878-4. Online ahead of print.
PMID: 41620779DERIVEDOtis NP, Kline AC, Glassman LH, Michael Hunt W, Walter KH. Sudden gains in cognitive processing therapy with and without behavioral activation among service members with comorbid PTSD and MDD. Behav Res Ther. 2025 Jul;190:104753. doi: 10.1016/j.brat.2025.104753. Epub 2025 Apr 22.
PMID: 40288269DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
William M. Hunt, Ph.D.
United States Naval Medical Center, San Diego
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Research Psychologist
Study Record Dates
First Submitted
August 2, 2016
First Posted
August 22, 2016
Study Start
October 20, 2015
Primary Completion
March 18, 2022
Study Completion
March 18, 2022
Last Updated
November 15, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share
Data will be available only in aggregate